An experimental model of hypersensitivity pneumonitis in rats was used to analyze ultrastructural changes in cellular elements of the epithelium and alveolar lumen, in an attempt to correlate the immunological mechanisms responsible for these pulmonary lesions. Semifine and ultrafine sections of pulmonary tissue of immunized and intratracheally challenged rats were analyzed and compared with their respective controls. A thickening of the alveolar walls and an increase in the number of macrophages and type II pneumocytes were observed in the semifine sections. The ultrastructural examination revealed appreciable changes in morphology, size and location of both types of cells. The membranes of the macrophages showed evident alterations and the type II pneumocytes, an increase in size and number of cytoplasmic inclusions corresponding to surfactant. The cellular changes observed are consistent with phenomena of cellular activation, which can be attributed to the release of soluble mediators by T lymphocytes. The important delayed hypersensitivity phenomena based on the morphology of pulmonary lesions in this model contribute data to the pathogenic interpretation of hypersensitivity alveolitis.

Keywords:
Hypersensitivity pneumonitis, Alveolar macrophages, Type II pneumocytes
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.